Nov 14, 2025 • Zacks Commentary
NEUTRAL
Down 28.6% in 4 Weeks, Here's Why Impinj ( PI ) Looks Ripe for a Turnaround
Impinj (PI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Nov 07, 2025 • Benzinga
SOMEWHAT-BULLISH
This Aardvark Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Foghorn Therapeutics ( NASDAQ:FHTX ) , Aardvark Therapeutics ( NASDAQ:AARD )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Nov 07, 2025 • Zacks Commentary
NEUTRAL
Gen Digital Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
GEN's strong Q2 earnings and 25% revenue jump highlight surging demand for its AI-driven cyber safety tools.
Nov 07, 2025 • Zacks Commentary
NEUTRAL
IREN Shares Slip 12% on Q1 Earnings Miss, Revenues Rise Q/Q
IREN shares fall after Q1 earnings miss estimates, but soaring revenues, stronger liquidity, and bold AI targets hint at growth ahead.
Nov 06, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
MTSI Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
MACOM Technology's Q4 earnings and revenues beat estimates with strong year-over-year growth and solid guidance for fiscal 2026.
Nov 06, 2025 • Zacks Commentary
NEUTRAL
SMCI Q1 Earnings Surpass Expectations, Revenues Decline Y/Y
Super Micro Computer beats Q1 earnings estimates but misses on revenues, as margins narrow and free cash flow turns negative.